FARALLON CAPITAL MANAGEMENT LLC
Q4 2020 13F-HR Holdings
Net value change ($000)
+1,265,068
(9.0%)
New positions
34
Sold out positions
28
Turnover %
28.8%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q3 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| ARMK | 424,202 | NEW |
| RTX | 324,820 | NEW |
| TIFFANY & CO | 300,626 | NEW |
| AVGO | 272,778 | NEW |
| WTW | 192,339 | 1842.2% |
| QGEN | 172,120 | NEW |
| IQV | 168,571 | 30.3% |
| BSX | 159,695 | 50.5% |
| FATE | 147,884 | 118.4% |
| V | 144,064 | 42.0% |
Top Reduces (Value $000, Stocks/ETFs)
| IMMUNOMEDICS INC | -498,276 | -100.0% |
| IHS Markit Ltd. | -299,354 | -100.0% |
| ABBV | -249,035 | -66.9% |
| PANW | -217,312 | -100.0% |
| BMY | -210,580 | -93.1% |
| GD | -176,790 | -100.0% |
| MyoKardia, Inc. | -167,004 | -100.0% |
| Wright Medical Group N.V. | -155,679 | -100.0% |
| EQIX | -152,151 | -100.0% |
| ALNY | -129,230 | -74.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
516,289
(3.4% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|